MAKO Surgical Corporation

According to J.P. Morgan, Mako Surgical (NASDAQ: MAKO) is reducing its estimates. J.P. Morgan reported that, following 4Q results, it is updating its Mako model and maintaining the Neutral rating. “Mako reported 4Q10 results that were in line with the company's previously announced metrics,...

JP Morgan has downgraded MAKO Surgical Corporation (NASDAQ: MAKO) from Overweight to Neutral and maintains its $17 price target.